Estrogenic hormones, such as 17(3-estradiol (E2), play important roles in normal physiologic processes, as well as disease states. The long-term objective of these studies is to gain a better understanding of the molecular mechanisms underlying the control of gene expression by E2 acting through estrogen receptor alpha (ERa), a ligand-regulated, DMA-binding transcription factor. In particular, we are interested how the activity of ERa is modulated by its associated coregulatory proteins in the chromatin environment of the nucleus. In this regard, we are focusing our studies on poly(ADP-ribose) polymerase-1 (PARP-1), a chromatin-dependent transcriptional coregulator, and macroH2A, an ADP-ribose-binding histone variant that binds to PARP-1. PARP-1, the most abundant member of a family of poly(ADP-ribose) polymerases, is a chromatin-binding nuclear enzyme that catalyzes the polymerization of ADP-ribose chains on target proteins from donor nicotinamide adenine dinucleotide (NAD+) molecules. Recent studies have revealed important roles for PARP-1 as a coregulator of ERa. Our broad hypothesis is that the coregulatory activity of PARP- 1 at E2-regulated promoters is determined by (1) the local chromatin environment (e.g., chromatin composition, histone modifications) and (2) physical and functional interactions among PARP-1, ERa, other coregulators, and components of chromatin. We have planned a series of experiments using a multidisciplinary approach with a complementary set of biochemical, biophysical, cell-based, and genomic approaches that will test our broad hypothesis and address three specific aims: (1) Define the set of E2-regulated genes that are direct targets for coregulation by PARP-1 and macroH2A by using genomic approaches, (2) Determine the molecular mechanisms underlying the chromatin-dependent regulation of E2 target genes by PARP-1 and macroH2A by using cell-based assays, and (3) Determine the biochemical mechanisms underlying the chromatin-dependent regulation of ERa transcriptional activity by PARP-1 and macroH2A by using biochemical assays. An underlying theme in this work is the connection between nuclear NAD+ metabolism and the regulation of PARP-1 and macroH2A activity. Collectively, these studies will provide new insights into the molecular mechanisms of PARP-1's coregulatory activity, especially those relevant to ERa-dependent transcription in the context of macroH2A-containing chromatin. In addition, these studies will provide new insights into the role of nuclear NAD+ signaling in hormone-regulated transcription, an exciting new area that is only now beginning to be understood. Given the roles of PARP-1 and ERa in human disease, our studies could also lead to new ways to exploit these factors as therapeutic targets.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
High Priority, Short Term Project Award (R56)
Project #
2R56DK069710-04
Application #
7439950
Study Section
Special Emphasis Panel (ZRG1-EMNR-G (05))
Program Officer
Margolis, Ronald N
Project Start
2004-09-30
Project End
2008-08-31
Budget Start
2007-09-01
Budget End
2008-08-31
Support Year
4
Fiscal Year
2007
Total Cost
$365,257
Indirect Cost
Name
Cornell University
Department
Biochemistry
Type
Schools of Earth Sciences/Natur
DUNS #
872612445
City
Ithaca
State
NY
Country
United States
Zip Code
14850
Liu, Ziying; Kraus, W Lee (2017) Catalytic-Independent Functions of PARP-1 Determine Sox2 Pioneer Activity at Intractable Genomic Loci. Mol Cell 65:589-603.e9
Gibson, Bryan A; Zhang, Yajie; Jiang, Hong et al. (2016) Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation. Science 353:45-50
Hussey, Kristine M; Chen, Hongshan; Yang, Christine et al. (2014) The histone variant MacroH2A1 regulates target gene expression in part by recruiting the transcriptional coregulator PELP1. Mol Cell Biol 34:2437-49
Zhang, Xuesen; Gamble, Matthew J; Stadler, Sonja et al. (2011) Genome-wide analysis reveals PADI4 cooperates with Elk-1 to activate c-Fos expression in breast cancer cells. PLoS Genet 7:e1002112
Gamble, Matthew J; Frizzell, Kristine M; Yang, Christine et al. (2010) The histone variant macroH2A1 marks repressed autosomal chromatin, but protects a subset of its target genes from silencing. Genes Dev 24:21-32
Langelier, Marie-France; Ruhl, Donald D; Planck, Jamie L et al. (2010) The Zn3 domain of human poly(ADP-ribose) polymerase-1 (PARP-1) functions in both DNA-dependent poly(ADP-ribose) synthesis activity and chromatin compaction. J Biol Chem 285:18877-87
Krishnakumar, Raga; Kraus, W Lee (2010) PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. Mol Cell 39:736-49
Zhang, Tong; Kraus, W Lee (2010) SIRT1-dependent regulation of chromatin and transcription: linking NAD(+) metabolism and signaling to the control of cellular functions. Biochim Biophys Acta 1804:1666-75
Krishnakumar, Raga; Kraus, W Lee (2010) The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Mol Cell 39:8-24
Kininis, Miltiadis; Isaacs, Gary D; Core, Leighton J et al. (2009) Postrecruitment regulation of RNA polymerase II directs rapid signaling responses at the promoters of estrogen target genes. Mol Cell Biol 29:1123-33

Showing the most recent 10 out of 11 publications